ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_795 # 824547 # 824663 # 1 # ID=1_795;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.496	scaffold_1_795 	824547	824663	+	Strict	850	21.1718	OpmB	100.0	3004072	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGATGATGAAGGCTTGAAGAAGGAAGCTGAAGGTTGGAGGTGTCATAGCGACACATGGTGTTGCGGAGGCGTTTTGACTTGGCCTTTCGAGATAAGGGGGTTGATTCATGAGTGA	MDDEGLKKEAEGWRCHSDTWCCGGVLTWPFEIRGLIHE	MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP	7.63	gnl|BL_ORD_ID|2374|hsp_num:0	2716	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_904 # 945968 # 946057 # 1 # ID=1_904;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.433	scaffold_1_904 	945968	946057	+	Strict	700	19.2458	Mef(En2)	100.0	3004659	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTAGATTGCAATATGTTTGGGGATGGTGATAATGGTGGATATTGGGTTGAGGCTTGCTATGAAGGAGCATCGACAGAAAACAAGTGA	MVDCNMFGDGDNGGYWVEACYEGASTENK	MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLFAGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPALQASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACLTLLCVQIPSLQKTKVLPDFKKELTEWLHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFMTLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYLPSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVASGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA	7.23	gnl|BL_ORD_ID|2255|hsp_num:0	3359	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_1358 # 1411395 # 1411520 # -1 # ID=1_1358;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.587	scaffold_1_1358 	1411395	1411520	-	Strict	940	20.4014	mdsC	100.0	3000791	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTAATCGGAGAGGGTGGAGGTTGGAGAGAGGTGTTTCCCGGCGTGGACGAGACGGAGGTCAGTTTCGGGGAGGGAGGTGCGGACGGAGAGGAGGGTGGTGAGGTTTTGGATGCTGAGATCTGA	MVIGEGGGWREVFPGVDETEVSFGEGGADGEEGGEVLDAEI	MRTALIRMISKHNDGNGIMKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG	8.15	gnl|BL_ORD_ID|1113|hsp_num:0	1180	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_579 # 612954 # 613151 # 1 # ID=3_579;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.374	scaffold_3_579 	612954	613151	+	Strict	500	21.9422	FONA-6	100.0	3004793	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FONA beta-lactamase	GTGGTTTTTGAATTAGATCTAGTCGGTTGGTTACGGTTATATTCGAAATATACGTACTTGTGTTGTTTTCTGCAGAAACGAGCAAGCGAATGGATGAAAGGTAACACGAATGAGGTAATCTGTCGAACCCTCAGCGAAGAAGATAATATAGAGATGTCACTTGCGCTATTTTCATGTTTGTTGAATAAAAACAAGTGA	MVFELDLVGWLRLYSKYTYLCCFLQKRASEWMKGNTNEVICRTLSEEDNIEMSLALFSCLLNKNK	MVKNTLRQTTLMVATVMPLLFGSAPLWAQTANAKANIQQQLSELEKSSGGRLGVALIDTADNSQILYRADERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGDKTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL	22.03	gnl|BL_ORD_ID|2391|hsp_num:0	3590	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_614 # 650341 # 650577 # -1 # ID=3_614;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.549	scaffold_3_614 	650341	650577	-	Strict	400	21.1718	vanRM	100.0	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGACCAAGGCAACACCCTCTACCCGTGGCAAAGCAACTCGGGGACGCGGAAAGGCAAAGAACGCCCGCCCAGCCAAAAAGACCGCAGAGGAACTCGACTCTGAGATGGTCGACTATTTTGGTGGTGGAAATACTGAGACAGATGCTGCTACTGCTGGCACCGCCCAGCCAGCCGCAGGAGGTGATGCAAATATGGATGATGAGATTCTGGTAAGTCTGTGTTGCGATCACCTTTGA	MTKATPSTRGKATRGRGKAKNARPAKKTAEELDSEMVDYFGGGNTETDAATAGTAQPAAGGDANMDDEILVSLCCDHL	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	33.62	gnl|BL_ORD_ID|709|hsp_num:0	752	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_696 # 732959 # 733093 # 1 # ID=3_696;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.422	scaffold_3_696 	732959	733093	+	Strict	1200	20.4014	TaeA	100.0	3003986	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCTCGAATTACTGGGAGTGATTTCACTATTACCCTGTCTGATACGGTTTAAGCCTGCTGCATGGATAAGAGGGTGCTTAAATGCTAAATGTGGAGAATACCGTGGTGTATTAGGACCTACGGTAAAACTGTAA	MLELLGVISLLPCLIRFKPAAWIRGCLNAKCGEYRGVLGPTVKL	MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS	6.79	gnl|BL_ORD_ID|2291|hsp_num:0	2522	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_953 # 986865 # 987137 # -1 # ID=3_953;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.425	scaffold_3_953 	986865	987137	-	Strict	550	21.557	SHV-148	100.0	3001187	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	GTGTATCGACAACATACTGATGCGCTAAGAAAATCCATTGATTATGTGGAGAATTATATAGTAGAGGCTCGAATAGTATTAATTGAGCACTGGCAACAAAGTCCTGGGTTTGTACTATGGACATATGGGAATGCAAAGGCTGTTCAGTCAATTTGGTTGGTGGAGCCCAGTTCAGCTAGCCTTGCTAGCTGCTTGAGCAAGTCGTCCCTTAAACTTAAGGAGGAAGTGGCCGAGTATTGTCCTGAAAGCTATAAGGATGAAAGTGAAGGCTAG	MYRQHTDALRKSIDYVENYIVEARIVLIEHWQQSPGFVLWTYGNAKAVQSIWLVEPSSASLASCLSKSSLKLKEEVAEYCPESYKDESEG	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQQ	31.47	gnl|BL_ORD_ID|1652|hsp_num:0	1753	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_2077 # 2176057 # 2176305 # -1 # ID=3_2077;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.586	scaffold_3_2077 	2176057	2176305	-	Strict	1900	21.9422	AcrF	100.0	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTTGGCGAACCACGGAGCTCTTGCCTGGGAAATTTGGAACTGCATGGTTAAGACAGGGCTTCGCTATAATTATATGGGGGCAACGAGGCCAATTGGGCGGCACACCGGCGGATTACTTGTCTTATGCGCGCGGAAATTGGGGGGAAGGGGTTGGTGGACGGGGGGGTTTGGAGGGGGGAGATGGGAGGAGGCTGAGGAACGAGTGGCGCGTGCTGGGTGAGAGTGGAAGCGAGTGCACGTTTTGA	MSWRTTELLPGKFGTAWLRQGFAIIIWGQRGQLGGTPADYLSYARGNWGEGVGGRGGLEGGDGRRLRNEWRVLGESGSECTF	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	7.93	gnl|BL_ORD_ID|1351|hsp_num:0	1437	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_305 # 331924 # 332247 # 1 # ID=5_305;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.460	scaffold_5_305 	331924	332247	+	Strict	720	22.3274	tet(57)	100.0	3005006	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCAAAAGCGAGACTTCACTGGAGCCAAGAAAGCCTTCTCTGATGCTCTGTATCTTGGCAGGCTAGCTAGCGGGGAGCAATTTCCAACGGAGATTGACCTTTATTGTATTGAATGCTTGGTATCAATGTTATCGGATGACGAGTATATTAAAGGTGAGACTCTATTGCAGGAGGCGTTGGGGAAATGCATGGAACGTGAAAACTGGGGGCGCTACGATTGGCGTACAAGTTCTATCCTAGGATCGTTGGAGTGTCTTTTAGAAAAGCAAGAGAAGTTTCATGAGGCTGAAATGCTTAGGCTACAGTATCCTGAGGCCTTCTAG	MQKRDFTGAKKAFSDALYLGRLASGEQFPTEIDLYCIECLVSMLSDDEYIKGETLLQEALGKCMERENWGRYDWRTSSILGSLECLLEKQEKFHEAEMLRLQYPEAF	MNKFAITALTITALDAMGIGLIMPVLPALLREYVSIEHLANHYGILLALYAIMQVFFAPLLGRWSDKFGRRPILLISLAGAALDYTLLALSSSLWMLYLGRLASGITGATGAVAASVIADHTQPQQRTKWFGRLGAAFGVGLIAGPAIGGFAGQLSPHLPFVIAAVLNACSFVVIWVIFKDQRKAVIQDAQHGDQPSPIPFMQIIKPIIQLLFVFFMAQLIGQIPATTWVLFTEGRFQWDSMQVGLSLAGLGVMHALFQAFVAGAIAKKFNEKVTIIVGFALDGSAFIILSLLAEGWLIYPTLILLAGGSIALPALQSLMSAQVNQANQGKLQGVLVSLTNATGVIGPLLFSVIFGQTLTMWDGWVWVIGAIMYVFLIVFILSFYRSSRPTIKQQTDN	26.88	gnl|BL_ORD_ID|2799|hsp_num:0	3750	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_613 # 659859 # 659948 # 1 # ID=5_613;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.489	scaffold_5_613 	659859	659948	+	Strict	1200	20.7866	tet(44)	100.0	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGAGGGGAAAGTAGAGGGGAACAGTCTTTCAGGGGAGAGATTCAGTCCCTTCCCGATCAAGATTGAGGAGAGGGAGGTTAATTTGTGA	MEGKVEGNSLSGERFSPFPIKIEEREVNL	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	4.53	gnl|BL_ORD_ID|1106|hsp_num:0	1171	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_1005 # 1085488 # 1085625 # -1 # ID=6_1005;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.486	scaffold_6_1005 	1085488	1085625	-	Strict	600	20.0162	AAC(3)-Ib/AAC(6')-Ib''	100.0	3002600	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3); AAC(6')	GTGAGGGGAACAGCTTGGCGGTTTGCTGCTATTGTTGTTGAGTTATATAGTTGTTTAGGTGCGTGGTGGGGTGGTGAAGGAAAGGTGAGTCAAAATTGCGAAGCGAGTTACAGGTCACGTGTGAGGCTTAAGGTATGA	MRGTAWRFAAIVVELYSCLGAWWGGEGKVSQNCEASYRSRVRLKV	MSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQPTNEYLANLLHSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLKRVAVELGAYVIYVQADYGDDPAVALYTKLGVREDVMHFDIDPLTNSNDSVTLRLMTEHDLAMLYEWVNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGGGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	13.47	gnl|BL_ORD_ID|194|hsp_num:0	209	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_1568 # 1694885 # 1695040 # -1 # ID=6_1568;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.449	scaffold_6_1568 	1694885	1695040	-	Strict	2000	21.1718	oqxB	100.0	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTGTGGCATGGAGGCGCATGTGTATGATTGGGCTTTTACTCCGAAGTGGACTTCATGGAAGAACCCTATATGCTGTCTGTCCATTACATCTATTCTTGACGTCCAAGTGGACCGTGATAACTGGATTAGTAGGGACATGAATTGTGAACTATGA	MCGMEAHVYDWAFTPKWTSWKNPICCLSITSILDVQVDRDNWISRDMNCEL	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	4.86	gnl|BL_ORD_ID|2211|hsp_num:0	2400	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_75 # 91835 # 92182 # -1 # ID=7_75;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.399	scaffold_7_75 	91835	92182	-	Strict	500	22.7126	NDM-10	100.0	3002360	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGACTCGTTCGTGGAATGAATCTGACATGCTTTTAGCTGTTCAATTCGTACGACAAAACCCTAAAGCTAACATTCGTAAAACTACACGAATTTATAAAGTGCCTCGTACAACCCTATGTCGCCGAATCCAAGGCACACCTACACGACTTGATATCGTCAACAAAGCTCAAAAGCTTACAAAACTAGAAGAGGAAACTATTGTACGATATATTCTTGATTTAGATTCGCGAGCATTTCCTTCTTGGTATAGTGCTGTTGAAGATATAGCAAATCGATTACTTATAGTACGCGATGGCGGACGCGTTGGAAAGAACTGGACTTCAAACTTCGTACGACGACAACTATAA	MTRSWNESDMLLAVQFVRQNPKANIRKTTRIYKVPRTTLCRRIQGTPTRLDIVNKAQKLTKLEEETIVRYILDLDSRAFPSWYSAVEDIANRLLIVRDGGRVGKNWTSNFVRRQL	MELPNIMHPVAKLSTALAAALMLSGCMPGEISPTIDQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPSFGAVTSNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDRTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	42.59	gnl|BL_ORD_ID|60|hsp_num:0	70	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_601 # 620754 # 620954 # -1 # ID=8_601;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.433	scaffold_8_601 	620754	620954	-	Strict	475	22.7126	cphA3	100.0	3003093	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	ATGGGCGGGGGATTTGGCAGGTCTCAGCATTTAATAGATTTTAACGCCACTACTTACACGGAAGTACTTAGCTTCCACTTTACACCTACTGCTAACGATGATGAGAGGGCATTTTATGCCGGGCCTGCTGTAAGCATAAATGACTTACTAATCATGCCGTTTCAAGCTTCTAAGAGCACCCACTTTGAATTAGTACATTGA	MGGGFGRSQHLIDFNATTYTEVLSFHFTPTANDDERAFYAGPAVSINDLLIMPFQASKSTHFELVH	MMKGWIKCTLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEELIKAVPQS	25.98	gnl|BL_ORD_ID|1591|hsp_num:0	1687	True	loose hit with at least 95 percent identity pushed strict
scaffold_9_814 # 867744 # 867968 # 1 # ID=9_814;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.440	scaffold_9_814 	867744	867968	+	Strict	1190	22.7126	novA	100.0	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGCCACAGTACTACTCTACGGCGCCATTTGGTGAGGATTGTTTGTATTTGAATATTTATACGCCAGTGGATTCGAATTGTACAAAAGATGAGCTGCTACCGGTCTTTGTTTGGATTCATGGAGGCGGCATGAATGTTGGGGGGATTCAGACGCAGTATCAGTTACCAATGAAGTGGGTTGAGAGGACGCGGGATCATATTGTCGTACAGATTAAGTATTTTTGA	MPQYYSTAPFGEDCLYLNIYTPVDSNCTKDELLPVFVWIHGGGMNVGGIQTQYQLPMKWVERTRDHIVVQIKYF	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	12.03	gnl|BL_ORD_ID|1140|hsp_num:0	1210	True	loose hit with at least 95 percent identity pushed strict
scaffold_9_1039 # 1114983 # 1115102 # -1 # ID=9_1039;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.425	scaffold_9_1039 	1114983	1115102	-	Strict	400	19.631	vatE	100.0	3002844	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGGGGGCTTCATGTGCGAACTTGAAGGTTATGACGATTCCAGACGCGAATAAGTGTAAGGTTTCGAGGAAGTATGAGGAGAATTATGAAGGATGGATTGATAAGTTGCCTGGTATGTAA	MGASCANLKVMTIPDANKCKVSRKYEENYEGWIDKLPGM	MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGDKLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQTTPTLELINSLMEK	18.22	gnl|BL_ORD_ID|1430|hsp_num:0	1519	True	loose hit with at least 95 percent identity pushed strict
scaffold_10_734 # 804888 # 805028 # 1 # ID=10_734;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.475	scaffold_10_734 	804888	805028	+	Strict	550	23.8682	OXA-472	100.0	3003628	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGAGGGTAAGGAGATTTACATGACAGTGCATGCACCGATTCCACCGGCTCCCTTGGCGATTGGTGCTCTTGGGGTCTCCATTGTAATTTTTGGGTTCGCTGGTTGGTTTGTTGGTTGGTTGATAAAACTTTTGGTTTGA	MEGKEIYMTVHAPIPPAPLAIGALGVSIVIFGFAGWFVGWLIKLLV	MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAELRFYQASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQVPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQIKLLTKLAQNELPYPIEIQKAVSDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLENDNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	17.16	gnl|BL_ORD_ID|2699|hsp_num:0	3534	True	loose hit with at least 95 percent identity pushed strict
scaffold_10_832 # 918439 # 918888 # -1 # ID=10_832;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.433	scaffold_10_832	918439	918888	-	Strict	32	33.113	Trimethoprim-resistant dihydrofolate reductase DfrA42	29.9	3005334	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGGCCGCAAAACTTGGGATAGTATACCACCCAAATTTCGACCTCTAAAAGACCGCCATAACATCGTCATTTCTCGTACACTCCCGCCAAGTTCGAAACCTGACTCCTCACCTAGTACGATTTTCAATTCGTTATCTGAAGCAGTTGAAAGTTTGTCACAACCAACCAGCGAATCAGGAAAAGCATTCATAATTGGTGGTGCTCAAATTTATGGCGCTGCGCTAGAGAAGAAAGAGACAAAAAGAATATTATTAACCAGAATATTAAGTGATTTCGAGTGTGATACTATATTTCCTGTGACGCTACCAGAGAGTGGAGAAGTAGATGGCTGGAAAAGGAAGAGTAAGGAGGAACTGGATGCTTGGGTTGGGGAGACGGTCCCTGAGGGGGAGCAGGAGGAAAATGGGACAAAGTATGTTTTTGAGATGTGGGAGAGGATTGAATCATAA	MGRKTWDSIPPKFRPLKDRHNIVISRTLPPSSKPDSSPSTIFNSLSEAVESLSQPTSESGKAFIIGGAQIYGAALEKKETKRILLTRILSDFECDTIFPVTLPESGEVDGWKRKSKEELDAWVGETVPEGEQEENGTKYVFEMWERIES	MHKPTPLKRLSMILARDLNGAIGYEGSLAIKSDNDFAWYKKITKPFKHAVCGRVTYEEDLPDIVKKRHRFIIITRNPDKYASTPEAQYMTLSDALKELQVWDVPGHDIICLGGAEIYKALLPYVSTVYLTTFFSVADEADTYFNDFTDKWESVGATWFNDCYCTRLERVCQSTNNII	84.18	gnl|BL_ORD_ID|3105|hsp_num:0	4066		
scaffold_11_207 # 210959 # 211099 # -1 # ID=11_207;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.461	scaffold_11_207 	210959	211099	-	Strict	980	20.0162	opcM	100.0	3003037	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGACGGGTGTTGGAAATGTAGTGGGATCTGTTTATATATGTGAATCTTCTGAAAGTAGGTTGGGCGGAGGGTGGGGTGGGGAAGCTAATATTGGAAAATACTTACGAGGAGGAGGAACCGTATGTTGCTTGATCTGA	MGTGVGNVVGSVYICESSESRLGGGWGGEANIGKYLRGGGTVCCLI	MDNMHNTNGLMRFAKVAAASTLLATLLAACAVGPDYQRPDAVVPAAFKEAPTLAAGEQAGTWKTAEPSDGRTPRRMVKVFGDPVLDSLETQALAANQNLKAAAARVEEARAATRSARSQWFPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNVEASRADQAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYHRTVELREQALKLVQRRFNEGDISELDVSRAKNELASAQADAVDVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKIPPGLPSALLERRPDVSAAERAMAAANARIGLAKSAYFRSSISPGRSAISVDARQPVPVVEPYFLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQGANYRQQVLVAFREVEDNLADLRLLDDQIRAQEAAVNASRRAATLSRSEYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVSTVNLIRALGGGWGNAPAPTAVGDAASGKADVAAR	8.98	gnl|BL_ORD_ID|1964|hsp_num:0	2130	True	loose hit with at least 95 percent identity pushed strict
scaffold_13_324 # 348187 # 348462 # -1 # ID=13_324;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.449	scaffold_13_324 	348187	348462	-	Strict	500	21.9422	TEM-196	100.0	3001376	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	GTGGATATTTTGCCAGAGGTCAATAGTACTGTTTTGTGCAAGGTTACCAGGATTACGACGAGGCAGGCACATGTTAGTATACTTGTGGTAGGAGAGACGGTGTTGGATGGGGAATGGCAGGGCCTCATCCGTGTCCAAGATGTCAGAGCCACTGAGAAAGATAAAGTTAAAATATTTGAGAGTTTTAGGCCCGGGGATATCGTTAGGGCTGTTGTGGTAGGCTGGCTCTTTTTGTGGAATATTGAATGGAGGAAGAGGCTAATGAGAAATAGATAA	MDILPEVNSTVLCKVTRITTRQAHVSILVVGETVLDGEWQGLIRVQDVRATEKDKVKIFESFRPGDIVRAVVVGWLFLWNIEWRKRLMRNR	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKIFESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	31.82	gnl|BL_ORD_ID|1947|hsp_num:0	2064	True	loose hit with at least 95 percent identity pushed strict
scaffold_13_389 # 403687 # 403818 # -1 # ID=13_389;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.417	scaffold_13_389 	403687	403818	-	Strict	530	21.1718	OXA-899	100.0	3005093	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGATCAAAGATCAAAGGACTGAGGGGAGATGTGATGAAAGAGAAGAGGATGAGTATGAGAAGAAGAGGTTGAAGTTGGATGGGGAAGTTTTTGTATTCGGAAAAGGGATCTGGACAGCTAAAAAGTTTTGA	MIKDQRTEGRCDEREEDEYEKKRLKLDGEVFVFGKGIWTAKKF	MMKRRHAATGALLAALATFAHAEHPICTIVADGATGKAVLQEGRCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGFMRRIVNRQLPVSARTYEMVDRTVQTWQVPGGWSVHGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALLARLPEVLAFAGQ	15.64	gnl|BL_ORD_ID|2869|hsp_num:0	3826	True	loose hit with at least 95 percent identity pushed strict
scaffold_13_499 # 515817 # 515924 # 1 # ID=13_499;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.602	scaffold_13_499 	515817	515924	+	Strict	700	19.2458	tet(A)	100.0	3000165	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTTAAAAGAAGCCGACCCGGGTTTTGAGGAGGGGGGGGTTGCTGATGTGGGCGGGAGGAGGAAGGAGCAGGAGGGGGGTTTGATGGGGGGATTCCGTGTTGGGTAA	MLKEADPGFEEGGVADVGGRRKEQEGGLMGGFRVG	MSTNLSVIKNPRVQSDQRRLVRRPDVKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACAPVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAMLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT	8.25	gnl|BL_ORD_ID|1835|hsp_num:0	1808	True	loose hit with at least 95 percent identity pushed strict
scaffold_14_911 # 961092 # 961229 # 1 # ID=14_911;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.493	scaffold_14_911 	961092	961229	+	Strict	450	21.1718	rmtF	100.0	3002666	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGATACAAGTTGGTGACGGGTGTCCGACTCGGACACTGGGAGGAAGGCATATGCGACATCTTTGTTCTGGGAAGAGATCTGAGGTAGGAAGATCGAAGCTGGGTTATATGGAAACGATACAGCTTGGACGACGTTGA	MIQVGDGCPTRTLGGRHMRHLCSGKRSEVGRSKLGYMETIQLGRR	MDERAQAALDALLSAKNLRDVCPETVRRVFMELLPRYRKPKDAEKAARTHLHQITGAFMTADAQKKARALLARWNEGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLACGLNPILLGSMGVTNALGMDIHLGCVRLVNETARARGWHTRARACDLLSEIPAEEADAALLMKLLPVLEAQKTGRAAELLASLRAPRLVVTFPTRTLGGRGVGMEKHYADWFERILPDTLSVRDRFTVSDELVYLVERT	17.37	gnl|BL_ORD_ID|1749|hsp_num:0	1852	True	loose hit with at least 95 percent identity pushed strict
scaffold_15_828 # 876211 # 876342 # -1 # ID=15_828;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.462	scaffold_15_828 	876211	876342	-	Strict	700	20.0162	mdtG	100.0	3001329	protein homolog model	n/a	n/a	fosfomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCCATCCTACGCTTTCTACTAGGAGCCCGTAAGCCGCAGAATTCTCCGGGATGGGAAGCAGCCCAAGTCAGTTGTAATAATGAGGATAATAAGAATGAAGAGATAGGAAAGGTGCAAGGGATTCGGTAA	MPILRFLLGARKPQNSPGWEAAQVSCNNEDNKNEEIGKVQGIR	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	10.54	gnl|BL_ORD_ID|564|hsp_num:0	603	True	loose hit with at least 95 percent identity pushed strict
scaffold_17_1016 # 1063303 # 1063911 # -1 # ID=17_1016;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.471	scaffold_17_1016 	1063303	1063911	-	Strict	550	23.8682	CME-1	100.0	3004775	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CME beta-lactamase	ATGAACGCAATAGCAGACTATTATGATATACCACAGCTGAAACAGCTTGCAAACACGAAAATCCAACCCCTCCTCGAAAATACCTGGTCTCCTGATAATTTCTCTGACATCGTTAGAGAAGTTTTCAACTCCACTAGCGACACAGCACTGCGCAAGATAATGGCTTCAACCGCGGCTACGCACATGGAAGAGCTCGTTGAGCTCGAGGATTTTGCTACGCTAGATGCCATGAGCGAGTTCGCCATCAGCATCATACGGACCATCATTGCGGCATACAAGGACAGGGAGGATTTGTCTACGCAGAAACTTCAAGCTGTCCAATCTCAGCTACAACAAACAAAGTCTCGCCTTCAATCTGCCGAGCAAGATTGCTCTGATGAGAAGTCATTGCGTGACCGCGCAACTACTAGGGCTGATCATATCATCGAAAATGTTGACAATTGCATTGAGATCCTCTCCAAGACTAGGACTTGTCGCAATCCCCGTTGCGAAGCCGACTTCACCTGTTATATTGAACGTGGCGGTTTTATAGATGAGCCCAAATACACACTTCGGTGCGCAAGGTGCCGCTGCAGACATAAGGATAGTTGGAATTTGAGGGGATTGTAA	MNAIADYYDIPQLKQLANTKIQPLLENTWSPDNFSDIVREVFNSTSDTALRKIMASTAATHMEELVELEDFATLDAMSEFAISIIRTIIAAYKDREDLSTQKLQAVQSQLQQTKSRLQSAEQDCSDEKSLRDRATTRADHIIENVDNCIEILSKTRTCRNPRCEADFTCYIERGGFIDEPKYTLRCARCRCRHKDSWNLRGL	MKKIILLFILTSQLVLAQHTSILNDINAVTKDKKATVAVSVLGIENDFQFSNANGNLKMPMLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPDGNVELPLSEIITYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGIKNFQIKYNEEEMHKNDVKTLYANYTTTASMVKTLKAFYKGMFLSKRSTIFLMDIMTKTNTGMSKLPGLLPKVRMARKTGSSGKMKNGLTIAENDSGIVTLANGKHYAIAVFVKDSMESEEVNCGMIAQVSKIVWDALNKKK	68.47	gnl|BL_ORD_ID|2682|hsp_num:0	3575	True	loose hit with at least 95 percent identity pushed strict
scaffold_19_82 # 78287 # 78445 # 1 # ID=19_82;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.415	scaffold_19_82 	78287	78445	+	Strict	700	20.7866	ACC-3	100.0	3001817	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	GTGTATTTTGGTTACGGTACTATCCTATCTCCTGGAAGAATTGATGTTGGTAGGTTCTGGTCTTGGGCGGAAGTTTTCAAGAATAATATTCCTGGAATGGTGTGTGTTATGAAGTGCATGTTGGTAGATGCTCCCATATTACTCATGTGCTTCCGATAG	MYFGYGTILSPGRIDVGRFWSWAEVFKNNIPGMVCVMKCMLVDAPILLMCFR	MRKKMQNTLKMLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVTLNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYVPELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIGTGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNMEVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWEQLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVT	13.79	gnl|BL_ORD_ID|1337|hsp_num:0	1422	True	loose hit with at least 95 percent identity pushed strict
scaffold_19_131 # 132032 # 132241 # -1 # ID=19_131;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.400	scaffold_19_131 	132032	132241	-	Strict	300	21.1718	vanXYE	100.0	3002967	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	GTGGATATTGTCTATGTCGGCACACCTCATTCTTTACACTTGGAGAATTGTCTTGCTGCAATTGAGAAAGGAAAACATGTGCTTTGTGAAAAACCATTAGCAATTAATGAGAAGCAATCAAAGGTTATTGTTGATGCTGCGAGGGAGAAGGGGGTTTTTCTTATGGAAGGTACGCTCTCTGTCCTAATTCTTCCTAATCTCGCAACCTGA	MDIVYVGTPHSLHLENCLAAIEKGKHVLCEKPLAINEKQSKVIVDAAREKGVFLMEGTLSVLILPNLAT	MKKNYLRLINENNEIKDSERPSHLVQAPFAQTNILVDPMVAIQLEKLIKTTGLDSQIITIDGYRSKETQQALWDETIQEKGLEFAHKYVAKPGCSEHEIGLAVDLGLATKENDFIRPSFTDSPIVDKFLKHMTDFGFILRYQKGKESITNINYEPWHFRYVGTPHSSIMVQQNWVLEEYIEFIESIRGTAYEA	35.75	gnl|BL_ORD_ID|522|hsp_num:0	559	True	loose hit with at least 95 percent identity pushed strict
scaffold_20_374 # 403172 # 403327 # 1 # ID=20_374;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.436	scaffold_20_374 	403172	403327	+	Strict	560	21.9422	OXA-302	100.0	3001757	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCATTTTCTGGTTGTGGGTTTATGCATTGCGCTTTTGTCTGGTGGACTGGATGGACTTATGGCGTTGGTTGGCATGTATTTTTGTTATGGGCGGAAAATGACGCCATGATGCATGCTGGAGCGATAATACTGCGTTATTTCATGCATAAATAG	MAFSGCGFMHCAFVWWTGWTYGVGWHVFLLWAENDAMMHAGAIILRYFMHK	MMMSKKLKCLALLTPCILILQLTACQSVSQQKQQLSTQTNEQQQISSLFQSAQTKGVLVIYDGKKIQSYGNDLNRAEQRYIPASTFKILNALIGIQYHKTTPNEVFKWDGKKRTFSSWEKDLSLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLQITPVEEVRFVYALAKQKLPFDQSTQQQVKGMLLADERQGTKIYAKSGWGMDVSPQVGWWTGWIEQPNGKTIAFSLNMQMSQPEHANARKVIVYQALQELGLLAN	18.21	gnl|BL_ORD_ID|2458|hsp_num:0	3464	True	loose hit with at least 95 percent identity pushed strict
scaffold_20_770 # 818878 # 819021 # 1 # ID=20_770;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.326	scaffold_20_770 	818878	819021	+	Strict	600	20.4014	TLA-2	100.0	3003203	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; cephalosporin	antibiotic inactivation	TLA beta-lactamase	ATGTGGAACGGGTTTTGGGATTACTTTGTCAAGGCTTTACATAGTTATGCTGTTCACATTAAGCTAAGTTATTTTACATGCCACCTTAATATTTTAAAATATCTTGCATGTTACCTCATCTTCGCTCATTTAACTAATGATTAG	MWNGFWDYFVKALHSYAVHIKLSYFTCHLNILKYLACYLIFAHLTND	MNIKYFKFAEKFILLVLIMSFSSLAFCKSDDSLEQRINSIISGKKASVGVAVAGIEDNFSLSINGKKNFPMMSVYKLHIVLAVLNKVDGGSLKLDEKIPLNKKDLHPGTWSPLRDKYPNGGVSIPLSEIIEYTITQSDNNGCDILIALAGGTEAVKRYIISKGISDFDIRATEKECHESWNVQYSNWSTPVSAVALLKKFNDRKILSSVSTEYLMNVMIHTSTGNKRIKGLIPPSADVAHKTGTSGIRNGITPGTNDIGIVTLPNGKHFAIAVFVSDSRENNAANERIIAEISKAAWDYFVKMN	15.46	gnl|BL_ORD_ID|89|hsp_num:0	102	True	loose hit with at least 95 percent identity pushed strict
scaffold_21_547 # 584424 # 584564 # -1 # ID=21_547;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.383	scaffold_21_547 	584424	584564	-	Strict	540	20.0162	OXA-156	100.0	3001461	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTGGAAGTTTGGAACTGGAGTGGAGATTTTTGAGGTGGGTTATGGAAACCGTTTTACGAAGAGTCGGGTTTGCATCAAAGGGGAGTTGGTAGATAAGGCTTTATCTGATAGATGTATTTGGAAATTTAAAGTCTTTTAA	MWKFGTGVEIFEVGYGNRFTKSRVCIKGELVDKALSDRCIWKFKVF	MKKTFSRWRRGALVLRILGALASPVVFATPGHAAEPVRPPSVHITERADWGKYFADEGVKGTVVVLDGRTQTYQAYDAARAERRLSPASTYKIFNSLLALESGAIDNEREVIPWDGKPRSMKAWNAALNLRDAFRVSCLPCYQILSHKIPRQYAQAKLNEVGYGNRTIGHAADTYWVDDSLQISAREQVDFLQRLAKGTLPFSARSQDIVRNISIVEANADYVLHGKTGWFTDKKPDIGWWVGWLERDGNLTMIALNIDIQSDADGPKRVRIVRSVLKDLKLI	16.25	gnl|BL_ORD_ID|2636|hsp_num:0	3420	True	loose hit with at least 95 percent identity pushed strict
scaffold_24_666 # 666847 # 666951 # 1 # ID=24_666;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.552	scaffold_24_666 	666847	666951	+	Strict	800	20.0162	PDC-41	100.0	3005157	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGGATTTAGGGGCGCGCTTGCGGGGAGTTGTATTGGTGGATTTGGAGGGGGAACCGTTGGCTTTAATGGGAGAGGTGGTAGGGCCGGGGCCTTTAGATTTATAG	MDLGARLRGVVLVDLEGEPLALMGEVVGPGPLDL	MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITLKGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWPALQGSRFDGISLLDLGTYTAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNPSIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDHPLRVGPGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEAYDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRDVGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR	8.56	gnl|BL_ORD_ID|2924|hsp_num:0	3882	True	loose hit with at least 95 percent identity pushed strict
scaffold_26_348 # 362654 # 362797 # -1 # ID=26_348;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.431	scaffold_26_348 	362654	362797	-	Strict	2090	20.0162	mdsB	100.0	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCATAATGGTCTTGGATTGGGGTTGATCGCCCTCTGTTTTGGCTCCAGTTGCCTTGTAACATGTATTTTTGATTGGTTGATAGGGCTGTCAGGATGGCAAGCATATTTATTGGTTCGAGATGAACTTGCGAGGTTGAATTAG	MHNGLGLGLIALCFGSSCLVTCIFDWLIGLSGWQAYLLVRDELARLN	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	4.45	gnl|BL_ORD_ID|1301|hsp_num:0	1385	True	loose hit with at least 95 percent identity pushed strict
scaffold_27_337 # 381539 # 381643 # -1 # ID=27_337;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.371	scaffold_27_337 	381539	381643	-	Strict	450	20.0162	rmtA	100.0	3000859	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAATCGAGAGAATGAGATTCAAGTTTTAGTAATGACACCGGGCCTGAGAATTGAAAGAAGTACGGCACTGCCTGATGAATTTGAGAAAAGAATAAAAGAATGA	MNRENEIQVLVMTPGLRIERSTALPDEFEKRIKE	MSFDDALASILSSKKYRSLCPDTVRRILDQEWGRHKSPKLAVEATRTRLHGICGAYVTPESLKAAAAALSVGDVQKALSLHASTKERLAELDCLYDFIFSGGVPHRVLDIACGLNPLALFIRDITSVWACDIHQGLGDVITPFAHHQGLDFTFALQDVMCTPPTETGDLALVFKLLPLLEREQAGAAMALLQALATPRIAVSFPTRSLGGRGKGMEANYSAWFEGALPDEFEIEDTKTIGIELVYMIKRNK	13.55	gnl|BL_ORD_ID|1751|hsp_num:0	1854	True	loose hit with at least 95 percent identity pushed strict
scaffold_27_712 # 816160 # 816273 # -1 # ID=27_712;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.465	scaffold_27_712 	816160	816273	-	Strict	700	20.0162	ACT-36	100.0	3003171	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGGCTTGTGTTCAGGTCAAGGTTAGGGTGAGCCCAGGAATGCTCAAGAATGTTCACCCTCAGCTCAGGTTAAAAGTGGTAGCTGCTCAGGCCCATATACCAAAACAGAACTAA	MACVQVKVRVSPGMLKNVHPQLRLKVVAAQAHIPKQN	MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALTVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	9.71	gnl|BL_ORD_ID|622|hsp_num:0	663	True	loose hit with at least 95 percent identity pushed strict
scaffold_28_646 # 678095 # 678304 # -1 # ID=28_646;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.381	scaffold_28_646 	678095	678304	-	Strict	950	21.557	fusH	100.0	3003026	protein homolog model	n/a	n/a	fusidic acid	antibiotic inactivation	fusidic acid inactivation enzyme	ATGTATGATGGGAGATACAATGACGCTGAATCCGACGAGAAAGAGCTTCATAGAAGAGAAAATTGTGTTAGAATATTAATTCAAGCTGGTGGAGACCCCTCTCTCGAAATGGATATTGGGTGGGGTAGGTTTGTAACTGGTTTCATGCATGCTATCCACAGCTTGTCATTTGTCAGTATAACTAGTTTTAAACGATTTTATATGTATTAA	MYDGRYNDAESDEKELHRRENCVRILIQAGGDPSLEMDIGWGRFVTGFMHAIHSLSFVSITSFKRFYMY	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	13.56	gnl|BL_ORD_ID|65|hsp_num:0	75	True	loose hit with at least 95 percent identity pushed strict
scaffold_30_594 # 623317 # 623475 # -1 # ID=30_594;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.409	scaffold_30_594 	623317	623475	-	Strict	250	20.7866	arr-5	100.0	3002850	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGGGAAAAAGCCAGGTTAGGGGACCATTTTATATAAGCCACAAAATCTTTAAAGTTGGTGAAGAAGCCGCTAAGTTGGATGAATTCTTGTACCCCATCGCGAAGCGCTTCATTAGGACTTTGGAATATTCAAGTGTGCAGGAGACGAAAGATTCGTAG	MGKSQVRGPFYISHKIFKVGEEAAKLDEFLYPIAKRFIRTLEYSSVQETKDS	MTVDWIPISHDNYHQVRGPFYHGTKAELAIGDLISTGFISHFERDRALKHVYFSALMEPAIWGAELAVALSGSDGPGHIYIIEPTGPFEDDPNLTNKRFPGNPTQSYRTCHPLKIVGILREWERHSPEALKTMLDSLADLKRRGLAIIEE	34.67	gnl|BL_ORD_ID|510|hsp_num:0	547	True	loose hit with at least 95 percent identity pushed strict
scaffold_31_91 # 107411 # 107548 # -1 # ID=31_91;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.435	scaffold_31_91 	107411	107548	-	Strict	3000	20.4014	abcA	100.0	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTAATGCAGAGTCGGAGTATAATCCAGAATACTAAGGGTCATTTGACGGTAGATTATACATCTGGTAAGCTTGGATCTCCATCACAAAAAGAGGGGTTAGTTGAAGCCGGCGAAGGACAGGGTCTTGGTGGTTGA	MLMQSRSIIQNTKGHLTVDYTSGKLGSPSQKEGLVEAGEGQGLGG	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	3.10	gnl|BL_ORD_ID|2224|hsp_num:0	2416	True	loose hit with at least 95 percent identity pushed strict
scaffold_57_28 # 38821 # 39042 # -1 # ID=57_28;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.500	scaffold_57_28 	38821	39042	-	Strict	550	21.557	LRA-7	100.0	3002486	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	TTGATCTTCGCCACCTGTGTTGGAGGCGGATGCGAAGATGGTGATTCCGGCGTTGACACACTTCTCGATTTCGTTATAAAGCTCGTGACAGGGTTTGTGGAAACCAAAAGACATGGATATGATGTCGACATTCCACGTTTCCCTGACATACTTCAAGGCCTATGGGGTGCAATTGTCAGTCGAATGCGCCCTGCTCCAGAGGGTCGCCAAGACAAATGTTAG	MIFATCVGGGCEDGDSGVDTLLDFVIKLVTGFVETKRHGYDVDIPRFPDILQGLWGAIVSRMRPAPEGRQDKC	MRSKFLLATALVLSTAFTADAADAPKRLPVNITNQDWLKPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVADMASFKKDAPSAVVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVLQAYGHTPGATSFQFQQTDAGKTYNVMIVNMNGINAGVKLLGSPKYPTIVEDFKNTIDMQATYKPDIWVSSHAGQFNLHQVYKPGDAYNPARFGDQAAYQQKIATAKANYEKQLAEERAAAK	24.17	gnl|BL_ORD_ID|1962|hsp_num:0	2121	True	loose hit with at least 95 percent identity pushed strict
